• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH LA 1 SCREENING REAGENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH LA 1 SCREENING REAGENT Back to Search Results
Model Number LA 1 SCREENING REAGENT
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 02/13/2018
Event Type  malfunction  
Manufacturer Narrative
The customer contacted siemens and reported that they obtained a discordant, falsely elevated lupus anticoagulants (la) 1 screening reagent clotting time patient result on a bcs xp system using the la 1 screening reagent.The customer reported that they receive frozen samples.Upon receipt, the customer thaws the samples in a 37 degrees water bath for 5-10 minutes prior to placing it on a rocker.The sample is then rocked for 5-20 minutes.The customer also reported that they conduct a medical review of abnormal results by comparing the abnormal result to results obtained on other parameters for the patient.A siemens headquarters support center (hsc) specialist contacted the customer to investigate the cause of the event and determined that preventive maintenance (pm) is performed as required and up to date for both systems.The customer reported that their lab has 4 bcs xp systems and independent reagent vials are loaded into each system.A discordant result was obtained on a specific sample aliquot, which potentially contained small bubbles or foam that may have led to inadequate sample aspiration.The hsc specialist determined that inadequate sample aspiration and the use of different reagent vials and systems, utilized to test the same sample, potentially contributed to the different results obtained on the patient sample.The sample was repeated within 2.5 hours and while the customer has validated the stability of 8 hours for thawed samples for la assays, this has not been confirmed by siemens.The hsc specialist determined that the results from the other screening tests (aptt and factor viii) generally reflects that the patient was not under anticoagulants.The hsc specialist determined there is no indication of a system malfunction, medication interference or poor blood collection process.The hsc specialist also determined that the customer used siemens application as base assays.A siemens field service engineer (fse) was dispatched to the customer's site for rotor handler and rack transfer errors on 15-feb-2018.The hsc specialist determined that this service was unrelated to this event.The cause of the event is unknown.The systems and reagent are performing according to specifications.No further evaluation of these systems and reagent is required.Mdr 9610806-2018-00032 and mdr 9610806-2018-00034 were filed for the same event.
 
Event Description
A discordant, falsely elevated lupus anticoagulants (la) 1 screening reagent clotting time result was obtained on a patient sample on a bcs xp system using the la 1 screening reagent.Due to the elevated result, the sample was tested for la 2 confirmation reagent clotting time and a ratio was calculated from these results.Based on the lab's ranges, the ratio signified that the patient was positive for la.None of these results were reported to the physician(s).The same sample was rerun on an alternate bcs xp system, resulting in a lower la 1 screening reagent clotting time result.The sample was also tested for la 2 confirmation reagent clotting time and a ratio was calculated from these results.The ratio signified that the patient was weakly positive for la.Since the patient's activated partial thromboplastin time (aptt) and factor viii results recovered within normal ranges, a la ratio of 1.3 was reported to the physician(s), who did not question the result.There are no known reports of patient intervention or adverse health consequences due to the discordant, falsely elevated la 1 screening reagent clotting time result.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LA 1 SCREENING REAGENT
Type of Device
LA 1 SCREENING REAGENT
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
emil-von-behring- str. 76
marburg, D-350 41
GM  D-35041
Manufacturer (Section G)
DSRV, INC.
registration #: 3004737529
330 waterloo valley rd ste 200
mount olive NJ 07828
Manufacturer Contact
christina lam
511 benedict ave
tarrytown, NY 10591
9145243504
MDR Report Key7339667
MDR Text Key102864187
Report Number9610806-2018-00033
Device Sequence Number1
Product Code GIR
UDI-Device Identifier00842768007477
UDI-Public00842768007477
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K922326
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Reporter Occupation Health Professional
Type of Report Initial
Report Date 03/14/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/14/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/10/2018
Device Model NumberLA 1 SCREENING REAGENT
Device Catalogue Number10461887
Device Lot Number549936A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received02/15/2018
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
-
-